top of page
Mission Statement

Our mission is to develop, manufacture, and deliver research tools for novel genomic sequencing and detection technology. By working closely with leading academic laboratories, we have and will continue to in-licence, develop and commercialize novel genomic sequencing reagents and methodology in Epigenetics.

Highlights

Important Note: TAB-seq βGT protection efficiency note

News

October, 2016 - Scientists from the Vesalius Research Center at KU Leuven in Belgium have published "Tumor hypoxia causes DNA hypermethylation by reducing TET activity" in Nature which describes the use of Wisgene's TABseq kit; the article is accessible here.

Wisegene LLC. Registered in the State of Illinois

  • Wix Facebook page
  • Wix Twitter page
  • Wix Google+ page
bottom of page